Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting
Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced that the company, along with its collaborators, will present new data at the 2024 American Society of Clinical...